These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 25961977)

  • 21. Brassica vegetable consumption shifts estrogen metabolism in healthy postmenopausal women.
    Fowke JH; Longcope C; Hebert JR
    Cancer Epidemiol Biomarkers Prev; 2000 Aug; 9(8):773-9. PubMed ID: 10952093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of energy deficiency on estrogen metabolism in premenopausal women.
    Westerlind KC; Williams NI
    Med Sci Sports Exerc; 2007 Jul; 39(7):1090-7. PubMed ID: 17596776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer: are estrogen metabolites carcinogenic?
    Mueck AO; Seeger H
    Climacteric; 2007 Oct; 10 Suppl 2():62-5. PubMed ID: 17882675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen metabolites and the risk of breast cancer in older women.
    Cauley JA; Zmuda JM; Danielson ME; Ljung BM; Bauer DC; Cummings SR; Kuller LH
    Epidemiology; 2003 Nov; 14(6):740-4. PubMed ID: 14569192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulatory effect of cigarette smoking on the 15 alpha-hydroxylation of estradiol by human term placenta.
    Zhu BT; Cai MX; Spink DC; Hussain MM; Busch CM; Ranzini AC; Lai YL; Lambert GH; Thomas PE; Conney AH
    Clin Pharmacol Ther; 2002 May; 71(5):311-24. PubMed ID: 12011817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The significance of estrogen metabolism for hormone-dependent neoplasms from the clinical-pharmacological viewpoint].
    Lippert TH; Seeger H; Mueck AO
    Arzneimittelforschung; 1999 Aug; 49(8):649-62. PubMed ID: 10483510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen metabolism as a risk factor for head and neck cancer.
    Yoo HJ; Sepkovic DW; Bradlow HL; Yu GP; Sirilian HV; Schantz SP
    Otolaryngol Head Neck Surg; 2001 Mar; 124(3):241-7. PubMed ID: 11240983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carcinogenic activities of various steroidal and nonsteroidal estrogens in the hamster kidney: relation to hormonal activity and cell proliferation.
    Li JJ; Li SA; Oberley TD; Parsons JA
    Cancer Res; 1995 Oct; 55(19):4347-51. PubMed ID: 7671246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue-selectivity: the mechanism of action of tibolone.
    Kloosterboer HJ
    Maturitas; 2004 Aug; 48 Suppl 1():S30-40. PubMed ID: 15337246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of polymorphic human cytochrome P450 enzymes in estrone oxidation.
    Cribb AE; Knight MJ; Dryer D; Guernsey J; Hender K; Tesch M; Saleh TM
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):551-8. PubMed ID: 16537715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of norethisterone acetate on estrogen metabolism in postmenopausal women.
    Seeger H; Mueck AO; Lippert TH
    Horm Metab Res; 2000 Oct; 32(10):436-9. PubMed ID: 11069210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct action of naturally occurring estrogen metabolites on human osteoblastic cells.
    Robinson JA; Waters KM; Turner RT; Spelsberg TC
    J Bone Miner Res; 2000 Mar; 15(3):499-506. PubMed ID: 10750564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of human breast cancer cell proliferation with estradiol metabolites is as effective as with tamoxifen.
    Seeger H; Huober J; Wallwiener D; Mueck AO
    Horm Metab Res; 2004 May; 36(5):277-80. PubMed ID: 15156405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of lifestyle factors on gynaecological cancer.
    Rieck G; Fiander A
    Best Pract Res Clin Obstet Gynaecol; 2006 Apr; 20(2):227-51. PubMed ID: 16543119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RESPONSE: re: urinary 2-Hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women.
    Ursin G; London S
    J Natl Cancer Inst; 1999 Nov; 91(21):1893A-1894. PubMed ID: 10547402
    [No Abstract]   [Full Text] [Related]  

  • 36. Endogenous estrogen metabolites as oxidative stress mediators and endometrial cancer biomarkers.
    Bukato K; Kostrzewa T; Gammazza AM; Gorska-Ponikowska M; Sawicki S
    Cell Commun Signal; 2024 Apr; 22(1):205. PubMed ID: 38566107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are estradiol metabolites involved in gynaecological carcinogenesis?
    Seeger H; Mueck AO
    Horm Mol Biol Clin Investig; 2010 Jan; 1(3):111-6. PubMed ID: 25961977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer: are oestrogen metabolites carcinogenic?
    Mueck AO; Seeger H
    Maturitas; 2007 May; 57(1):42-6. PubMed ID: 17383836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Estrogen-dependent neoplasia - what is the significance of estradiol metabolites].
    Mueck AO; Seeger H; Lippert TH
    Zentralbl Gynakol; 2003 Nov; 125(11):458-66. PubMed ID: 14634875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cells.
    Seeger H; Wallwiener D; Kraemer E; Mueck AO
    Maturitas; 2006 Apr; 54(1):72-7. PubMed ID: 16213115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.